DE122006000012I2 - Lhrh antagonistische peptide - Google Patents
Lhrh antagonistische peptideInfo
- Publication number
- DE122006000012I2 DE122006000012I2 DE122006000012C DE122006000012C DE122006000012I2 DE 122006000012 I2 DE122006000012 I2 DE 122006000012I2 DE 122006000012 C DE122006000012 C DE 122006000012C DE 122006000012 C DE122006000012 C DE 122006000012C DE 122006000012 I2 DE122006000012 I2 DE 122006000012I2
- Authority
- DE
- Germany
- Prior art keywords
- moiety
- lhrh
- peptide compound
- antagonistic peptides
- lhrh antagonistic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/480,494 US5843901A (en) | 1995-06-07 | 1995-06-07 | LHRH antagonist peptides |
PCT/US1996/009852 WO1996040757A2 (en) | 1995-06-07 | 1996-06-07 | Lhrh antagonist peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE122006000012I2 true DE122006000012I2 (de) | 2010-02-04 |
Family
ID=23908180
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69623254T Expired - Lifetime DE69623254T2 (de) | 1995-06-07 | 1996-06-07 | Lhrh antagonistische peptide |
DE122006000012C Active DE122006000012I2 (de) | 1995-06-07 | 1996-06-07 | Lhrh antagonistische peptide |
DE69535963T Expired - Lifetime DE69535963D1 (de) | 1995-06-07 | 1996-06-07 | LHRH antagonistische Peptide |
DE1996623254 Pending DE122006000012I1 (de) | 1995-06-07 | 1996-06-07 | Lhrh antagonistische Peptide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69623254T Expired - Lifetime DE69623254T2 (de) | 1995-06-07 | 1996-06-07 | Lhrh antagonistische peptide |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69535963T Expired - Lifetime DE69535963D1 (de) | 1995-06-07 | 1996-06-07 | LHRH antagonistische Peptide |
DE1996623254 Pending DE122006000012I1 (de) | 1995-06-07 | 1996-06-07 | Lhrh antagonistische Peptide |
Country Status (13)
Country | Link |
---|---|
US (4) | US5843901A (de) |
EP (2) | EP1188768B1 (de) |
JP (3) | JP4164125B2 (de) |
AT (2) | ATE432941T1 (de) |
AU (1) | AU715399B2 (de) |
CA (1) | CA2219460C (de) |
DE (4) | DE69623254T2 (de) |
DK (2) | DK1188768T3 (de) |
ES (2) | ES2326861T3 (de) |
HK (1) | HK1045161B (de) |
LU (2) | LU91225I2 (de) |
PT (2) | PT1188768E (de) |
WO (1) | WO1996040757A2 (de) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
US5780435A (en) | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
US5968895A (en) | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
WO1998028424A2 (en) | 1996-12-23 | 1998-07-02 | Immunex Corporation | Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
US5925730A (en) | 1997-04-11 | 1999-07-20 | Ferring Bv | GnRH antagonists |
AU735355B2 (en) * | 1997-04-15 | 2001-07-05 | Daiichi Sankyo Company, Limited | Novel protein and method for producing the protein |
US6316408B1 (en) * | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
TR199902512T2 (xx) | 1997-04-16 | 2000-06-21 | Amgen Inc. | Osteoprotegerin ba�lay�c� proteinler ve resept�rler. |
AU770565B2 (en) * | 1998-04-27 | 2004-02-26 | Praecis Pharmaceuticals Incorporated | Methods for treating hot flashes and gynaecomastia |
US6217844B1 (en) * | 1998-04-27 | 2001-04-17 | Praecis Pharmaceuticals, Inc. | Methods for detecting lesions in dense breast tissue using LHRH antagonists |
US6191115B1 (en) * | 1998-08-12 | 2001-02-20 | Abbott Laboratories | C-terminus modified heptapeptide LHRH analogs |
US6455499B1 (en) * | 1999-02-23 | 2002-09-24 | Indiana University Foundation | Methods for treating disorders associated with LHRH activity |
US6703367B1 (en) * | 1999-04-27 | 2004-03-09 | Praecis Pharmaceuticals Inc. | Methods for treating hot flashes and gynaecomastia |
CZ2002421A3 (cs) * | 1999-08-09 | 2002-09-11 | Tripep Ab | Prostředek pro potlačení aktivace transkripce, represe transkripce, sestavování bakteriálního holotoxinu, polymerizace aktinu, agregace beta-amyloidního peptidu, sestavování tubulínového komplexu, způsob potlačení, způsob léčby a prevence lidských chorob, Alzheimerovy choroby a rakoviny, způsob přípravy léčiva a léčivo |
CA2349406C (en) * | 1999-09-03 | 2011-01-11 | Amgen Inc. | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
US20030103978A1 (en) | 2000-02-23 | 2003-06-05 | Amgen Inc. | Selective binding agents of osteoprotegerin binding protein |
US7109171B2 (en) | 2000-02-28 | 2006-09-19 | Praecis Pharmaceuticals Inc. | Methods for treating FSH related conditions with GnRH antagonists |
AU2001267872A1 (en) | 2000-06-30 | 2002-01-14 | Suntory Limited | Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
US6598784B2 (en) * | 2000-12-20 | 2003-07-29 | Meadwestvaco Packaging Syatens, Llc | Beverage carton with strap type carrying handle |
AU2002235348A1 (en) * | 2001-01-17 | 2002-07-30 | Praecis Pharmaceuticals Inc. | Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
SI3351246T1 (sl) | 2001-02-19 | 2019-08-30 | Novartis Pharma Ag | Derivat rapamicina za zdravljenje trdnega tumorja, povezanega z deregulirano angiogenezo |
NZ529145A (en) | 2001-05-16 | 2005-07-29 | Novartis Ag | Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)- 2pyrimidine-amine and a chemotherapeutic agent |
AU2002324447B2 (en) | 2001-06-22 | 2006-06-29 | Durect Corporation | Zero-order prolonged release coaxial implants |
ES2907826T3 (es) | 2001-06-26 | 2022-04-26 | Amgen Inc | Anticuerpos para OPGL |
US6593455B2 (en) * | 2001-08-24 | 2003-07-15 | Tripep Ab | Tripeptide amides that block viral infectivity and methods of use thereof |
GB0128510D0 (en) * | 2001-11-28 | 2002-01-23 | Novartis Ag | Organic compounds |
US7718776B2 (en) | 2002-04-05 | 2010-05-18 | Amgen Inc. | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
MXPA04011384A (es) | 2002-05-16 | 2005-02-14 | Novartis Ag | Uso de agentes de union del receptor edg en cancer. |
US6861236B2 (en) | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
NZ564694A (en) | 2003-04-22 | 2009-11-27 | Sod Conseils Rech Applic | Peptide vectors |
GB0320806D0 (en) | 2003-09-05 | 2003-10-08 | Astrazeneca Ab | Therapeutic treatment |
JP4407322B2 (ja) * | 2004-03-09 | 2010-02-03 | 味の素株式会社 | ペプチドの製造方法 |
KR20080083220A (ko) | 2004-04-07 | 2008-09-16 | 노파르티스 아게 | Iap 억제제 |
GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
WO2006077428A1 (en) | 2005-01-21 | 2006-07-27 | Astex Therapeutics Limited | Pharmaceutical compounds |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
GT200600430A (es) | 2005-09-27 | 2007-05-21 | Compuestos de carboxiamina y metodos de uso de los mismos | |
US7942867B2 (en) * | 2005-11-09 | 2011-05-17 | The Invention Science Fund I, Llc | Remotely controlled substance delivery device |
GB0605120D0 (en) | 2006-03-14 | 2006-04-26 | Novartis Ag | Organic Compounds |
EP2272511A1 (de) | 2006-05-09 | 2011-01-12 | Novartis AG | Kombination aus einem Eisenchelatbildner und einem anti-neoplastischen Mittel und ihre Verwendung |
JP2010504933A (ja) | 2006-09-29 | 2010-02-18 | ノバルティス アーゲー | Pi3k脂質キナーゼ阻害剤としてのピラゾロピリミジン |
JP5528806B2 (ja) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
US8883790B2 (en) | 2006-10-12 | 2014-11-11 | Astex Therapeutics Limited | Pharmaceutical combinations |
KR20090110913A (ko) | 2007-02-15 | 2009-10-23 | 노파르티스 아게 | Lbh589와 암을 치료하기 위한 다른 치료제와의 조합물 |
WO2009118292A1 (en) | 2008-03-24 | 2009-10-01 | Novartis Ag | Arylsulfonamide-based matrix metalloprotease inhibitors |
NZ588069A (en) | 2008-03-26 | 2012-06-29 | Novartis Ag | Hydroxamate-based inhibitors of deacetylases b |
EP2370076B1 (de) * | 2008-11-28 | 2017-01-04 | Novartis AG | Pharmazeutische Zusammensetzung enthaltend einen Hsp 90-Inhibitor und einen mTOR-Inhibitor |
WO2010083617A1 (en) | 2009-01-21 | 2010-07-29 | Oncalis Ag | Pyrazolopyrimidines as protein kinase inhibitors |
WO2010085145A1 (en) | 2009-01-22 | 2010-07-29 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
EP2391366B1 (de) | 2009-01-29 | 2012-11-28 | Novartis AG | Substituierte benzimidazole zur behandlung von astrozytomen |
AU2010264698C1 (en) | 2009-06-26 | 2013-05-16 | Novartis Ag | 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17 |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
BR112012003262A8 (pt) | 2009-08-12 | 2016-05-17 | Novartis Ag | compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação |
EP2467383A1 (de) | 2009-08-20 | 2012-06-27 | Novartis AG | Heterocyclische oximverbindungen |
US20120149661A1 (en) | 2009-08-26 | 2012-06-14 | Novartis Ag | Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators |
JP2013504543A (ja) | 2009-09-10 | 2013-02-07 | ノバルティス アーゲー | 二環ヘテロアリール類のエーテル誘導体 |
JP5466767B2 (ja) | 2009-11-04 | 2014-04-09 | ノバルティス アーゲー | Mek阻害剤として有用なヘテロ環式スルホンアミド誘導体 |
JP2013512215A (ja) | 2009-11-25 | 2013-04-11 | ノバルティス アーゲー | 二環式ヘテロアリールのベンゼン縮合6員酸素含有ヘテロ環誘導体 |
US8614239B2 (en) | 2009-12-08 | 2013-12-24 | Novartis Ag | Heterocyclic sulfonamide derivatives |
US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
CU24130B1 (es) | 2009-12-22 | 2015-09-29 | Novartis Ag | Isoquinolinonas y quinazolinonas sustituidas |
UA112517C2 (uk) | 2010-07-06 | 2016-09-26 | Новартіс Аг | Тетрагідропіридопіримідинові похідні |
SG177783A1 (en) | 2010-07-09 | 2012-02-28 | Smart Communications Inc | Content provision system and method |
US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
US20130324526A1 (en) | 2011-02-10 | 2013-12-05 | Novartis Ag | [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
US20130338152A1 (en) | 2011-03-08 | 2013-12-19 | Irm Llc | Fluorophenyl bicyclic heteroaryl compounds |
AU2012249421B9 (en) | 2011-04-28 | 2015-10-22 | Novartis Ag | 17alpha-hydroxylase/C17,20-lyase inhibitors |
KR20140034898A (ko) | 2011-06-09 | 2014-03-20 | 노파르티스 아게 | 헤테로시클릭 술폰아미드 유도체 |
EP2721008B1 (de) | 2011-06-20 | 2015-04-29 | Novartis AG | Hydroxy substituierte isochinolinone als p53 (mdm2 or mdm4) inhibitoren |
US8859586B2 (en) | 2011-06-20 | 2014-10-14 | Novartis Ag | Cyclohexyl isoquinolinone compounds |
MX2013015001A (es) | 2011-06-27 | 2014-03-31 | Novartis Ag | Formas solidas y sales de derivados de tetrahidro-pirido-pirimidin a. |
JP5957526B2 (ja) | 2011-09-15 | 2016-07-27 | ノバルティス アーゲー | チロシンキナーゼとしての6−置換3−(キノリン−6−イルチオ)−[1,2,4]トリアゾロ[4,3−a]ピラジン |
US8969341B2 (en) | 2011-11-29 | 2015-03-03 | Novartis Ag | Pyrazolopyrrolidine compounds |
LT2794600T (lt) | 2011-12-22 | 2018-02-26 | Novartis Ag | 2,3-dihidro-benzo[1,4]oksazino dariniai ir giminingi junginiai kaip fosfoinozitido-3 kinazės (pi3k) inhibitoriai, skirti gydymui, pavyzdžiui, reumatoidinio artrito |
WO2013093850A1 (en) | 2011-12-22 | 2013-06-27 | Novartis Ag | Quinoline derivatives |
KR20140107574A (ko) | 2011-12-23 | 2014-09-04 | 노파르티스 아게 | Bcl2와 결합 파트너의 상호작용을 억제하기 위한 화합물 |
US9126980B2 (en) | 2011-12-23 | 2015-09-08 | Novartis Ag | Compounds for inhibiting the interaction of BCL2 with binding partners |
BR112014015322A2 (pt) | 2011-12-23 | 2017-06-13 | Novartis Ag | compostos e composições para inibir a interação de bcl2 com parceiros de ligação |
WO2013096055A1 (en) | 2011-12-23 | 2013-06-27 | Novartis Ag | Compounds for inhibiting the interaction of bcl2 with binding partners |
US20140350014A1 (en) | 2011-12-23 | 2014-11-27 | Novartis Ag | Compounds for inhibiting the interaction of bcl2 with binding partners |
JO3357B1 (ar) | 2012-01-26 | 2019-03-13 | Novartis Ag | مركبات إيميدازوبيروليدينون |
US9365576B2 (en) | 2012-05-24 | 2016-06-14 | Novartis Ag | Pyrrolopyrrolidinone compounds |
JP6427097B2 (ja) | 2012-06-15 | 2018-11-21 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | 癌を処置するための組成物および該組成物を製造するための方法 |
PL2903968T3 (pl) | 2012-10-02 | 2017-05-31 | Gilead Sciences, Inc. | Inhibitory demetylaz histonowych |
TW201422625A (zh) | 2012-11-26 | 2014-06-16 | Novartis Ag | 二氫-吡啶并-□衍生物之固體形式 |
US9403827B2 (en) | 2013-01-22 | 2016-08-02 | Novartis Ag | Substituted purinone compounds |
EP2948453B1 (de) | 2013-01-22 | 2017-08-02 | Novartis AG | Pyrazolo[3,4-d]pyrimidinonverbindungen als inhibitoren der p53/mdm2-interaktion |
WO2014128612A1 (en) | 2013-02-20 | 2014-08-28 | Novartis Ag | Quinazolin-4-one derivatives |
WO2014131777A1 (en) | 2013-02-27 | 2014-09-04 | Epitherapeutics Aps | Inhibitors of histone demethylases |
US20150018376A1 (en) | 2013-05-17 | 2015-01-15 | Novartis Ag | Pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide derivatives and use thereof |
UY35675A (es) | 2013-07-24 | 2015-02-27 | Novartis Ag | Derivados sustituidos de quinazolin-4-ona |
US9227969B2 (en) | 2013-08-14 | 2016-01-05 | Novartis Ag | Compounds and compositions as inhibitors of MEK |
WO2015022664A1 (en) | 2013-08-14 | 2015-02-19 | Novartis Ag | Compounds and compositions as inhibitors of mek |
WO2015022663A1 (en) | 2013-08-14 | 2015-02-19 | Novartis Ag | Compounds and compositions as inhibitors of mek |
EP3046563B1 (de) | 2013-09-22 | 2019-05-29 | Calitor Sciences, LLC | Substituierte aminopyrimidinverbindungen als pi3-kinase inhibitoren |
RU2016133285A (ru) | 2014-01-15 | 2018-02-20 | Новартис Аг | Фармацевтические комбинации |
JP6538148B2 (ja) | 2014-03-28 | 2019-07-03 | キャリター・サイエンシーズ・リミテッド・ライアビリティ・カンパニーCalitor Sciences, Llc | 置換されたヘテロアリール化合物および使用方法 |
EP3126345A1 (de) | 2014-03-31 | 2017-02-08 | Gilead Sciences, Inc. | Inhibitoren von histondemethylasen |
RU2016140160A (ru) | 2014-04-03 | 2018-05-07 | Инвиктус Онколоджи Пвт. Лтд. | Супрамолекулярные комбинаторные лекарственные средства |
SG11201701182VA (en) | 2014-08-27 | 2017-03-30 | Gilead Sciences Inc | Compounds and methods for inhibiting histone demethylases |
US10351591B2 (en) | 2015-03-20 | 2019-07-16 | The Regents Of The University Of California | Polypeptides, peptides, and proteins functionalized by alkylation of thioether groups via ring-opening reactions |
EP3124495A1 (de) | 2015-07-31 | 2017-02-01 | Centre National de la Recherche Scientifique (C.N.R.S.) | Derivate von elastin-ähnlichen polypeptiden und verwendungen davon |
US9938257B2 (en) | 2015-09-11 | 2018-04-10 | Calitor Sciences, Llc | Substituted heteroaryl compounds and methods of use |
US11732008B2 (en) | 2016-04-27 | 2023-08-22 | The Regents Of The University Of California | Preparation of functional homocysteine residues in polypeptides and peptides |
JP7254076B2 (ja) | 2017-11-19 | 2023-04-07 | サンシャイン・レイク・ファーマ・カンパニー・リミテッド | 置換ヘテロアリール化合物及び使用方法 |
US11602534B2 (en) | 2017-12-21 | 2023-03-14 | Hefei Institutes Of Physical Science, Chinese Academy Of Sciences | Pyrimidine derivative kinase inhibitors |
US10751339B2 (en) | 2018-01-20 | 2020-08-25 | Sunshine Lake Pharma Co., Ltd. | Substituted aminopyrimidine compounds and methods of use |
CN109926430A (zh) * | 2018-11-19 | 2019-06-25 | 云南省环境科学研究院(中国昆明高原湖泊国际研究中心) | 一种重金属废渣还原造锍熔炼处置的方法 |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3787385A (en) * | 1971-05-17 | 1974-01-22 | K Folkers | Synthetically produced tetrapeptide having the activity of the luteinizing hormone releasing hormone |
US3974135A (en) * | 1971-06-24 | 1976-08-10 | Karl Folkers | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for producing the same |
US3953416A (en) * | 1971-12-20 | 1976-04-27 | Karl Folkers | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same |
GB1541733A (en) * | 1975-10-29 | 1979-03-07 | Parke Davis & Co | Octapeptides and methods for their production |
BE847762A (fr) | 1975-10-29 | 1977-02-14 | Nouveaux nonapeptides et procedes pour les preparer, | |
DE2617646C2 (de) * | 1976-04-22 | 1986-07-31 | Hoechst Ag, 6230 Frankfurt | Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
US4215038A (en) * | 1978-10-16 | 1980-07-29 | The Salk Institute For Biological Studies | Peptides which inhibit gonadal function |
US4307083A (en) * | 1978-10-16 | 1981-12-22 | The Salk Institute For Biological Studies | LRF Antagonists |
US4244946A (en) * | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
US4409208A (en) * | 1980-04-15 | 1983-10-11 | The Salk Institute For Biological Studies | GnRH antagonists |
US4292313A (en) * | 1980-04-15 | 1981-09-29 | The Salk Institute For Biological Studies | LRF Antagonists |
US4377574A (en) * | 1980-06-26 | 1983-03-22 | The Salk Institute For Biological Studies | Contraceptive treatment of male mammals |
US4386074A (en) * | 1980-08-29 | 1983-05-31 | The Salk Institute For Biological Studies | LRF Antagonists |
US4341767A (en) * | 1980-10-06 | 1982-07-27 | Syntex Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
US4419347A (en) * | 1980-10-06 | 1983-12-06 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
US4489061A (en) * | 1981-06-12 | 1984-12-18 | The Salk Institute For Biological Studies | Treatment of male mammals |
US4481190A (en) * | 1982-12-21 | 1984-11-06 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
US4667014A (en) * | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
US4581169A (en) * | 1982-12-21 | 1986-04-08 | Syntex (U.S.A.) Inc. | Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists |
US4444759A (en) * | 1982-07-26 | 1984-04-24 | The Salk Institute For Biological Studies | GnRH Antagonists II |
US4619914A (en) * | 1983-03-10 | 1986-10-28 | The Salk Institute For Biological Studies | GNRH antagonists IIIB |
US4504414A (en) * | 1983-03-28 | 1985-03-12 | Board Of Regents, The University Of Texas System | Synthetic pyridyl-alanyl decapeptides having antiovulatory activity |
DE3467173D1 (en) * | 1983-08-16 | 1987-12-10 | Akzo Nv | Lh- rh antagonists |
US4547370A (en) * | 1983-11-29 | 1985-10-15 | The Salk Institute For Biological Studies | GnRH Antagonists |
US4569927A (en) * | 1984-02-23 | 1986-02-11 | The Salk Institute For Biological Studies | GnRH Antagonists IV |
US4652550A (en) * | 1984-05-21 | 1987-03-24 | The Salk Institute For Biological Studies | GnRH antagonists VII |
US4647653A (en) * | 1984-08-23 | 1987-03-03 | Tulane Educational Fund | Therapeutic peptides |
US4565804A (en) * | 1984-09-07 | 1986-01-21 | The Salk Institute For Biological Studies | GnRH Antagonists VI |
US4690916A (en) * | 1984-11-13 | 1987-09-01 | Syntex (U.S.A.) Inc. | Nona and decapeptide analogs of LHRH useful as LHRH antagonists |
US4740500A (en) * | 1985-01-31 | 1988-04-26 | The Salk Institute For Biological Studies | GnRH antagonists VIII |
US4659691A (en) * | 1985-02-08 | 1987-04-21 | Merck & Co., Inc. | Novel cyclic Hexapeptide LHRH antagonists |
US4677193A (en) * | 1985-02-22 | 1987-06-30 | The Salk Institute For Biological Studies | Peptides containing an aliphatic-aromatic ketone side chain |
US4866160A (en) * | 1985-04-09 | 1989-09-12 | The Administrators Of The Tulane Educational Fund | Therapeutic decapeptides |
US5003011A (en) * | 1985-04-09 | 1991-03-26 | The Administrators Of The Tulane Educational Fund | Therapeutic decapeptides |
US5073624A (en) * | 1985-04-09 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Therapeutic decapeptides |
US4642332A (en) * | 1985-04-26 | 1987-02-10 | The Board Of Regents, The University Of Texas System | Effective hormonal peptides: D-3-Pal6 -LHRH |
US4656247A (en) * | 1985-04-26 | 1987-04-07 | Board Of Regents, The University Of Texas System | Effective hormonal peptides: D-3-QA1 6-LHRH |
US4661472A (en) * | 1985-05-09 | 1987-04-28 | The Salk Institute For Biological Studies | GnRH antagonists IX |
US4721775A (en) * | 1985-08-26 | 1988-01-26 | Board Of Regents, The University Of Texas System | Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids |
US4705778A (en) * | 1985-10-22 | 1987-11-10 | Sri International | Orally active LHRH analogs |
US5182205A (en) * | 1986-11-27 | 1993-01-26 | Hoffmann-La Roche Inc. | Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor |
US4801577A (en) * | 1987-02-05 | 1989-01-31 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
US4851385A (en) * | 1987-07-15 | 1989-07-25 | Indiana University Foundation | LHRH antagonist analogs having low histamine-release activity |
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
US4935491A (en) * | 1987-08-24 | 1990-06-19 | Board Of Regents, The University Of Texas System | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
EP0400065B1 (de) * | 1988-02-10 | 1997-08-27 | TAP Pharmaceuticals Inc. | Lhrh-analog |
US5300492A (en) * | 1988-02-10 | 1994-04-05 | Tap Pharmaceuticals | LHRH analogs |
US5110904A (en) * | 1989-08-07 | 1992-05-05 | Abbott Laboratories | Lhrh analogs |
US5140009A (en) * | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
DK163689A (da) * | 1988-04-08 | 1989-10-30 | Sandoz Ag | Peptidderivater |
US4992421A (en) * | 1988-04-19 | 1991-02-12 | Abbott Laboratories | Luteinizing hormone releasing hormone antagonist |
US5258492A (en) * | 1988-10-21 | 1993-11-02 | The Administrators Of The Tulane Educational Fund | LHRH analogues with cytotoxic moieties at the sixth position |
US5171835A (en) * | 1988-10-21 | 1992-12-15 | The Administrators Of The Tulane Educational Fund | LHRH antagonists |
US5296468A (en) * | 1989-10-30 | 1994-03-22 | The Salk Institute For Biological Studies | GnRH analogs |
US5352796A (en) * | 1989-10-30 | 1994-10-04 | The Salk Institute For Biological Studies | Amino acids useful in making GnRH analogs |
US5169932A (en) * | 1989-10-30 | 1992-12-08 | The Salk Institute For Biological Studies | Gnrh analogs |
US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
US5180711A (en) * | 1990-06-14 | 1993-01-19 | Applied Research Systems Ars Holding N.V. | Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
CN1036343C (zh) * | 1990-11-10 | 1997-11-05 | 天津市计划生育研究所 | 新促黄体生成素释放激素拮抗类似物的制备方法 |
IL101074A (en) * | 1991-03-14 | 1997-09-30 | Salk Inst For Biological Studi | GnRH ANALOGS AND THEIR PREPARATION |
US5340585A (en) * | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
DK0593491T3 (da) * | 1991-04-25 | 1997-03-17 | Romano Deghenghi | Luteiniseringshormonfrigørende hormonantagonistpeptider |
DE4117507A1 (de) * | 1991-05-24 | 1992-11-26 | Schering Ag | Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten |
US5480969A (en) * | 1992-09-15 | 1996-01-02 | The Administrators Of The Tulane Educational Fund | Antagonists of LHRH |
US5371070A (en) * | 1992-11-09 | 1994-12-06 | The Salk Institute For Biological Studies | Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins |
EP0673254A4 (de) * | 1992-12-04 | 1998-11-18 | Abbott Lab | Lhrh antagonistische decapeptide in position 6 modifiziert. |
EP0683792B1 (de) * | 1992-12-18 | 2001-09-26 | Abbott Laboratories | Lhrh antagonisten mit modifizierten aminoacylresten an den positionen 5 und 6 |
RU2130464C1 (ru) * | 1993-05-20 | 1999-05-20 | Биотек Аустралиа Пти, Лимитед | Антагонист лг-рилизинг-фактора (lhrh), комплекс, способ химической кастрации и/или лечения гонадотропинзависимых расстройств |
DE4320201A1 (de) * | 1993-06-18 | 1995-01-12 | Asta Medica Ag | Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation |
US5502035A (en) * | 1993-08-06 | 1996-03-26 | Tap Holdings Inc. | N-terminus modified analogs of LHRH |
US5413990A (en) * | 1993-08-06 | 1995-05-09 | Tap Pharmaceuticals Inc. | N-terminus modified analogs of LHRH |
US5508383A (en) * | 1994-03-09 | 1996-04-16 | Tap Holdings Inc. | Cyclic peptide LHRH antagonists |
US5506207A (en) * | 1994-03-18 | 1996-04-09 | The Salk Institute For Biological Studies | GNRH antagonists XIII |
US5516759A (en) * | 1994-12-08 | 1996-05-14 | Tap Holdings Inc. | LHRH antagonists having lactam groups at the N-terminus |
US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
-
1995
- 1995-06-07 US US08/480,494 patent/US5843901A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 DE DE69623254T patent/DE69623254T2/de not_active Expired - Lifetime
- 1996-06-07 DK DK01204149T patent/DK1188768T3/da active
- 1996-06-07 DE DE122006000012C patent/DE122006000012I2/de active Active
- 1996-06-07 AT AT01204149T patent/ATE432941T1/de active
- 1996-06-07 JP JP50205097A patent/JP4164125B2/ja not_active Expired - Fee Related
- 1996-06-07 EP EP01204149A patent/EP1188768B1/de not_active Expired - Lifetime
- 1996-06-07 PT PT01204149T patent/PT1188768E/pt unknown
- 1996-06-07 ES ES01204149T patent/ES2326861T3/es not_active Expired - Lifetime
- 1996-06-07 DE DE69535963T patent/DE69535963D1/de not_active Expired - Lifetime
- 1996-06-07 DK DK96919311T patent/DK0794961T3/da active
- 1996-06-07 AT AT96919311T patent/ATE222924T1/de active
- 1996-06-07 EP EP96919311A patent/EP0794961B1/de not_active Expired - Lifetime
- 1996-06-07 PT PT96919311T patent/PT794961E/pt unknown
- 1996-06-07 CA CA002219460A patent/CA2219460C/en not_active Expired - Fee Related
- 1996-06-07 WO PCT/US1996/009852 patent/WO1996040757A2/en active Search and Examination
- 1996-06-07 US US08/973,378 patent/US6423686B1/en not_active Expired - Lifetime
- 1996-06-07 DE DE1996623254 patent/DE122006000012I1/de active Pending
- 1996-06-07 AU AU61680/96A patent/AU715399B2/en not_active Ceased
- 1996-06-07 ES ES96919311T patent/ES2177789T3/es not_active Expired - Lifetime
-
2002
- 2002-04-02 US US10/115,553 patent/US20030040482A1/en not_active Abandoned
- 2002-04-05 US US10/117,364 patent/US7071165B2/en not_active Expired - Fee Related
- 2002-09-11 HK HK02106667.7A patent/HK1045161B/zh not_active IP Right Cessation
-
2006
- 2006-03-03 LU LU91225C patent/LU91225I2/fr unknown
-
2007
- 2007-08-13 JP JP2007211155A patent/JP2007302695A/ja not_active Withdrawn
-
2008
- 2008-10-09 JP JP2008263288A patent/JP2009040793A/ja not_active Withdrawn
-
2011
- 2011-08-22 LU LU91857C patent/LU91857I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE432941T1 (de) | Lhrh antagonistische peptide | |
ES2103857T3 (es) | Peptidos ciclicos y su uso. | |
PT1288223E (pt) | Derivados de peptidos terapeuticos | |
DK0966297T4 (da) | Regulering af gastrointestinal motilitet | |
LV10720A (lv) | Peptidi un farmaceitiska kompozicija uz to bazes | |
DE69801369T2 (de) | Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen | |
ATE196296T1 (de) | Dolastatin analog | |
FI903971A0 (fi) | Peptid med bradykinin antagonistverkan. | |
DE60044945D1 (de) | Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür | |
ATE69556T1 (de) | Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute. | |
NZ231636A (en) | Anticoagulant peptides analogus to hirudins' active site | |
DE69002881T2 (de) | Peptide und deren Benutzung. | |
ATE46347T1 (de) | Immunostimulierende peptide. | |
IT8520273A0 (it) | Composizioni farmaceutiche adattivita' antigalattopoietica. | |
FR2717390B1 (fr) | Compositions thérapeutiques à base de peptides capables d'inhiber la libération de pepsine. | |
IT8720701A0 (it) | Composizioni farmaceutiche adattivita' immunomodulante. | |
IT8719949A0 (it) | Composizioni farmaceutiche adattivita' immunomodulante. | |
TH17650EX (th) | "อนุพันธ์เปปไทด์ที่ใช้รักษาโรค"(therapeutic peptide derivatives) | |
IT8847610A0 (it) | Composizioni farmaceutiche adattivita' antiprolattinica | |
IT8622051A0 (it) | Composizioni farmaceutiche adattivita' cicatrizzante. | |
IT8820026A0 (it) | Composizioni farmaceutiche adattivita' antineoplastica. |